HopeStage
Back to all studies
CompletedEUCTR 2011-000778-71

A Multicenter, Randomized, Double-Blind, Active Controlled, Comparative, Fixed-Dose, Dose Response Study of the Efficacy and Safety of BMS-820836 in Patients with Treatment Resistant Major Depress...

This historical record does not confirm current site availability.

Historical research recordMultiple countriesDepression
The study in practice

Understand this study

What did researchers investigate?

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.

Listed locations
Austria · Italy and 2 more locations
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateNot clearly listed
Recruitment status
Completed
Enrollment listed in the registry
1,500
Sponsor
Bristol-Myers Squibb International Corporation
Sponsor type
Other organization
Study type
Drug
Intervention type
Drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
United Kingdom, Austria, Italy, ...
Age range
Not clearly listed
Official registry ID
EUCTR 2011-000778-71
Official title
Show the full official title

A Multicenter, Randomized, Double-Blind, Active Controlled, Comparative, Fixed-Dose, Dose Response Study of the Efficacy and Safety of BMS-820836 in Patients with Treatment Resistant Major Depress...

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Austria · Italy · Spain

1 more locations
  • United Kingdom
Registry details
Historical country statuses

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Bristol-Myers Squibb International Corporation.

Want to explore more studies?

Explore studies